Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
lung cancer
Oct 23, 2023, 23:15 |
Blog
Christine Lovly: So proud to say Portia completed her PhD in my lab studying B7-H6 as an immune target in small cell Lung Cancer
Christine Lovly, Thoracic Oncologist & Physician Scientist at Vanderbilt University Medical Center, shared the following…
Oct 21, 2023, 23:53 |
Blog
Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers
Peter Lebowitz, SVP, Global Oncology Therapeutic Area Head at Janssen/Johnson and Johnson, made the following…
Oct 20, 2023, 19:52 |
Blog
David Kavanagh: Global burden of lung cancer incidence for the four main histological subtypes
David Kavanagh, Head of the Human Resources Office at the International Agency for Research on…
Oct 18, 2023, 16:51 |
Blog
Patrick Forde: ALINA adjuvant alectinib vs chemo for ALK post resected lung cancer
Quoting Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer…
Oct 18, 2023, 16:42 |
Blog
Andreas Charalambous: Secondary Prevention is key when it comes to lung cancer control.
Andreas Charalambous, President of the European Cancer Organisation, recently shared on LinkedIn: "Secondary Prevention is…
Oct 15, 2023, 17:54 |
Insight
Balazs Halmos: 4.1% annual drop in lung cancer deaths! If we keep this pace (or speed up) - can u imagine what might happen?
Balazs Halmos, Associate Director for Clinical Science at Montefiore Einstein Cancer Center, shared a post…
Oct 14, 2023, 18:23 |
Blog
Rami Manochakian: NEW ASCO and Ontario Health Guideline on Systemic Therapy for Small Cell Lung Cancer.
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared on X/Twitter: "Hot off the press…
Oct 14, 2023, 17:49 |
Drugs
Chris Boshoff: the U.S. FDA approved our targeted combination therapy for the treatment of adult patients with BRAF V600E-mutant metastatic non-small cell lung cancer (NSCLC).
Oct 13, 2023, 17:10 |
Drugs
Rami Manochakian: FDA Oncology approves the combination of Encorafenib and Binimetinib for Patients with metastatic Non-Small cell Lung Cancer with a BRAF V600E mutation.
Oct 10, 2023, 16:00 |
Blog
Rami Manochakian: FREE LIVE - "Cancer Education Symposium" for Patients with Lung Cancer and care givers on Saturday November 18th at the Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Florida.
40
41
42
43
44
All:
1556
Posts:
411 - 420
New management team at St. Anna Children's Hospital
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
Facebook
RSS Feed
Twitter
Linkedin
Youtube